Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia

Arslan, S., Zhang, J., Dhakal, P., Moran, J., Naidoo, N., Lombardi, J., … Aldoss, I. (2021, March 1). Outcomes of therapy with venetoclax combined with a hypomethylating agent in favorable-risk acute myeloid leukemia. American Journal of Hematology. Wiley-Liss Inc. https://doi.org/10.1002/ajh.26057